SHR-3045 Injection

SHR-3045 · Guangdong Hengrui Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-3045 Injection, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis [Phase 2]